Loading...
XNAS
AMIX
Market cap5mUSD
Sep 19, Last price  
1.06USD
1D
0.95%
1Q
-14.52%
IPO
-79.62%
Name

Autonomix Medical Inc

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
-11m
L-26.03%
-13,328,715-1,990,477-15,426,000-11,410,000
CFO
-8m
L+24.22%
-387,307-1,854,398-6,648,000-8,258,000

Profile

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
URL
https://autonomix.com/
IPO date
Jan 29, 2024
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFY
2025‑032024‑032023‑032022‑03
Income
Revenues
Cost of revenue
11,771
7,555
1,990
Unusual Expense (Income)
NOPBT
(11,771)
(7,555)
(1,990)
NOPBT Margin
Operating Taxes
(1,990)
Tax Rate
NOPAT
(11,771)
(7,555)
(477)
Net income
(11,410)
-26.03%
(15,426)
674.99%
(1,990)
-85.07%
Dividends
Dividend yield
Proceeds from repurchase of equity
10,027
13,706
675
BB yield
-324.45%
-620.58%
Debt
Debt current
Long-term debt
1,002
Deferred revenue
Other long-term liabilities
Net debt
(9,136)
(7,606)
(865)
Cash flow
Cash from operating activities
(8,258)
(6,648)
(1,854)
CAPEX
(14)
(19)
Cash from investing activities
(14)
(19)
Cash from financing activities
8,800
14,410
675
FCF
(11,770)
(7,577)
(477)
Balance
Cash
9,136
8,608
865
Long term investments
Excess cash
9,136
8,608
865
Stockholders' equity
(50,377)
(38,950)
(23,531)
Invested Capital
58,476
47,580
24,175
ROIC
ROCE
EV
Common stock shares outstanding
1,766
731
18,794
Price
1.75
-42.05%
3.02
 
Market cap
3,090
39.93%
2,209
 
EV
(6,046)
(5,397)
EBITDA
(11,588)
(7,474)
(1,990)
EV/EBITDA
0.52
0.72
Interest
176
79
Interest/NOPBT